Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route, Intervirology, vol.20, issue.1, pp.23-31, 1983. ,
Hepatitis E. Lancet Lond Engl, vol.379, pp.2477-88, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00409083
, European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection, J Hepatol. juin, vol.68, issue.6, pp.1256-71, 2018.
Update on hepatitis E virology: Implications for clinical practice, J Hepatol. 1 juill, vol.65, issue.1, pp.200-212, 2016. ,
Foodborne transmission of hepatitis E virus from raw pork liver sausage, France. Emerg Infect Dis, vol.20, pp.1945-1952, 2014. ,
Zoonotic transmission of hepatitis E virus from deer to human beings, Lancet Lond Engl. 2 août, vol.362, issue.9381, pp.371-374, 2003. ,
Risk factors and sources of foodborne hepatitis E virus infection in the United States, J Med Virol. 1 sept, vol.88, issue.9, pp.1641-1646, 2016. ,
HEV and transfusion-recipient risk, Transfus Clin Biol J Soc Francaise Transfus Sang. sept, vol.24, issue.3, pp.176-81, 2017. ,
Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient, J Hepatol. févr, vol.56, issue.2, pp.500-502, 2012. ,
Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study, Transplantation. août, vol.102, issue.8, pp.1351-1358, 2018. ,
, Hepatitis E Seroprevalence in Europe: A Meta-Analysis. Viruses, vol.06, issue.8, 2016.
A nationwide survey of hepatitis E viral infection in French blood donors, Hepatology. 1 avr, vol.63, issue.4, pp.1145-54, 2016. ,
Silent hepatitis E virus infection in Dutch blood donors, Eurosurveillance. 1 août, vol.18, issue.31, p.20550, 2011. ,
Hepatitis E and blood donation safety in selected European countries: a shift to screening? Eurosurveillance, vol.20 ,
Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates, J Infect Dis. 1 févr, vol.207, issue.3, pp.497-500, 2013. ,
Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. The Lancet, vol.384, pp.1766-73, 2014. ,
No artifact, hepatitis E is emerging, Hepatology. 1 août, vol.62, issue.2, pp.654-654, 2015. ,
Estimated Annual Numbers of Foodborne Pathogen-Associated Illnesses, Hospitalizations, and Deaths, Emerg Infect Dis, vol.23, issue.9, pp.1486-92, 2008. ,
Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy, J Viral Hepat. mai, vol.14, issue.5, pp.298-303, 2007. ,
Hepatitis E and Acute-on-Chronic Liver Failure, J Clin Exp Hepatol. sept, vol.3, issue.3, pp.225-255, 2013. ,
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants, Gastroenterology. mai, vol.140, issue.5, pp.1481-1490, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00926426
Extrahepatic manifestations of hepatitis E virus, Liver Int Off J Int Assoc Study Liver. avr, vol.36, issue.4, pp.467-72, 2016. ,
Hepatitis E virus: Infection beyond the liver?, J Hepatol, vol.66, issue.5, pp.1082-95, 2017. ,
Hepatitis E virus and neurological injury, Nat Rev Neurol. févr, vol.12, issue.2, pp.77-85, 2016. ,
Acute hepatitis E in French patients and neurological manifestations, J Infect. 1 sept, vol.77, issue.3, pp.220-226, 2018. ,
Guillain-Barre syndrome caused by hepatitis E infection: case report and literature review, BMC Infect Dis, vol.23, issue.2018 ,
Hepatitis E Virus-Induced Cryoglobulinemic Glomerulonephritis in a Nonimmunocompromised Person, Am J Kidney Dis. 1 avr, vol.67, issue.4, pp.660-663, 2016. ,
Severe thrombocytopenia associated with acute hepatitis E virus infection, J Clin Microbiol. juill, vol.46, issue.7, pp.2450-2452, 2008. ,
Acute pancreatitis: a rare complication of acute hepatitis E, J Clin Virol Off Publ Pan Am Soc Clin Virol. juill, vol.51, issue.3, pp.202-206, 2011. ,
Ribavirin for chronic hepatitis E virus infection in transplant recipients, N Engl J Med. 20 mars, vol.370, issue.12, pp.1111-1131, 2014. ,
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study, Liver Int Off J Int Assoc Study Liver. mars, vol.36, issue.3, pp.328-361, 2016. ,
Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin, Transpl Infect Dis Off J Transplant Soc. avr, vol.17, issue.2, pp.279-83, 2015. ,
Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis, Rev Med Virol. févr, vol.16, issue.1, pp.5-36, 2006. ,
Host Immune Status and Response to Hepatitis E Virus Infection, Clin Microbiol Rev. 1 janv, vol.27, issue.1, pp.139-65, 2014. ,
Serological diagnostics of hepatitis E virus infection. Virus Res, vol.161, pp.84-92, 2011. ,
Hepatitis E: An emerging infection in high income countries, J Clin Virol. 1 févr, vol.59, issue.2, pp.81-89, 2014. ,
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients, Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. janv, vol.16, issue.1, pp.74-82, 2010. ,
Diagnostic utility of hepatitis E virus antigen-specific ELISA versus PCR testing in a cohort of post liver transplant patients in a large university hospital, J Clin Virol Off Publ Pan Am Soc Clin Virol. sept, vol.106, pp.44-52, 2018. ,
Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients, J Clin Virol. déc, vol.58, issue.4, pp.624-632, 2013. ,
Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E, J Clin Virol Off Publ Pan Am Soc Clin Virol. juill, vol.45, issue.3, pp.259-61, 2009. ,
Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection, J Med Virol. mars, vol.86, issue.3, pp.478-83, 2014. ,
Letter: liver transplantation for acute HEV infection in cirrhotic patients in France, Aliment Pharmacol Ther. 1 août, vol.46, issue.4, pp.477-485, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01573755
Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study, Aliment Pharmacol Ther. sept, vol.42, issue.5, pp.574-81, 2015. ,
The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women, Aliment Pharmacol Ther. mars, vol.41, issue.5, pp.467-76, 2015. ,
Harmonised investigation of the occurrence of human enteric viruses in the leafy green vegetable supply chain in three European countries, Food Environ Virol. déc, vol.4, issue.4, pp.179-91, 2012. ,
Hepatitis E virus genotype 3 in shellfish, United Kingdom, Emerg Infect Dis. déc, vol.18, issue.12, pp.2085-2092, 2012. ,
Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series, BMC Infect Dis. 8 mai, vol.8, p.61, 2004. ,
Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study, J Hepatol, vol.67, issue.5, pp.925-957, 2017. ,
Acute hepatitis E in French patients and neurological manifestations, J Infect. sept, vol.77, issue.3, pp.220-226, 2018. ,
Acute hepatitis E in south-west France over a 5-year period, J Clin Virol Off Publ Pan Am Soc Clin Virol. janv, vol.44, issue.1, pp.74-81, 2009. ,
Hepatitis E virus genotype 4 in Southeastern France: still around, Liver Int Off J Int Assoc Study Liver, vol.36, issue.5, pp.765-772, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01459419
Infection with hepatitis E virus in kidney transplant recipients in southeastern France, J Med Virol. mars, vol.85, issue.3, pp.462-71, 2013. ,
Hepatitis E virus of subtype 3i in chronically infected kidney transplant recipients in southeastern France, J Clin Microbiol, vol.52, issue.11, pp.3967-72, 2014. ,
Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis, Hepatology. 1 janv, vol.67, issue.1, pp.446-454, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01791671
Hepatitis E virus infection as a promoting factor for hepatocellular carcinoma in Cameroon: Preliminary Observations, Int J Infect Dis IJID Off Publ Int Soc Infect Dis, vol.64, pp.4-8, 2017. ,
Hepatitis E Virus Infection, Clin Microbiol Rev. janv, vol.27, issue.1, pp.116-154, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01447684
Hepatitis E virus infection among solid organ transplant recipients, the Netherlands, Emerg Infect Dis. mai, vol.18, issue.5, pp.869-72, 2012. ,
Hepatitis E risks: pigs or blood-that is the question, Transfusion (Paris). 1 févr, vol.57, issue.2, pp.267-72, 2017. ,
Safety and efficacy of a recombinant hepatitis E vaccine, N Engl J Med. 1 mars, vol.356, issue.9, pp.895-903, 2007. ,
Long-term efficacy of a hepatitis E vaccine, N Engl J Med. 5 mars, vol.372, issue.10, pp.914-936, 2015. ,
Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection, Hepatol Baltim Md. mars, vol.55, issue.3, pp.695-708, 2012. ,
Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity, Proc Natl Acad Sci, vol.114, issue.27, pp.6914-6937, 2017. ,
Hepatitis E virus and chronic hepatitis in organ-transplant recipients, N Engl J Med. 21 févr, vol.358, issue.8, pp.811-818, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00409083
Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus, Hepatology. 1 déc, vol.64, issue.6, pp.1934-50, 2016. ,
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer, Oncogene. 28 avr, vol.30, issue.17, pp.1969-83, 2011. ,
Is Hepatitis C Virus Carcinogenic?, Gastroenterology. 1 mai, vol.142, issue.6, pp.1274-1282, 2012. ,
Protracted Fecal Shedding of HEV During Ribavirin Therapy Predicts Treatment Relapse, Clin Infect Dis. 1 janv, vol.60, issue.1, pp.96-105, 2015. ,
Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation, Clin Infect Dis Off Publ Infect Dis Soc Am. 1 mars, vol.50, issue.5, pp.30-33, 2010. ,
Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc, vol.15, pp.1225-1233, 2009. ,
Outcomes of acute rejection after interferon therapy in liver transplant recipients, Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. juill, vol.10, issue.7, pp.859-67, 2004. ,
Rejection under alpha interferon therapy in liver transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. janv, vol.7, issue.1, pp.177-84, 2007. ,
Meta-analysis: anti-viral therapy of hepatitis C virusrelated liver disease in renal transplant patients, Aliment Pharmacol Ther, vol.15, issue.10, pp.1413-1435, 2006. ,
Peginterferon alpha-2b and acute allograft failure in a heart transplant recipient, Ann Thorac Surg. mai, vol.89, issue.5, pp.1645-1652, 2010. ,
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C, Nat Rev Gastroenterol Hepatol. avr, vol.8, issue.4, pp.212-235, 2011. ,
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection, N Engl J Med. 16 mai, vol.368, issue.20, pp.1878-87, 2013. ,
Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation, Gastroenterology. 1 janv, vol.148, issue.1, pp.108-125, 2015. ,
Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation, Am J Transplant. 1 mai, vol.16, issue.5, pp.1474-1483, 2016. ,
Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin, Infection. 26 juin, 2018. ,
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin, Gastroenterology. janv, vol.150, issue.1, pp.82-85, 2016. ,
Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection, J Hepatol. 1 janv, vol.66, issue.1, pp.242-245, 2017. ,
Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient, Gastroenterology, vol.152, issue.1, pp.300-301, 2017. ,
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective, Antivir Ther. 5 mars, 2018. ,
, Mais cette infection peut avoir de lourdes complications chez les patients présentant une hépatopathie chronique, qui sont à risque de décompensation aiguë (ACLF), et chez les patients immunodéprimés, à risque de chronicisation et de cirrhose, Saisons / Années Résumé Introduction : L'hépatite E est un virus à ARN responsable de deux millions d'infections autochtones par an en Europe
Les dossiers médicaux de tous les patients ayant présenté une hépatite E, prouvée par PCR ,
, Résultats : Durant la période de l'étude 105 infections par le virus de l'hépatite E ont été diagnostiquées par PCR dans notre institution, la majorité de génotype 3 (n=85/105). L'âge médian des patients était de, p.55
, Seize patients ont développé une hépatite chronique et parmi eux un patient non immunodéprimé a vu son infection se compliquer d'une cirrhose. Un patient immunodéprimé ayant développé une cirrhose virale E qui s'est compliquée de carcinome hépato-cellulaire. Trois patients ont présenté une ACLF (Acute on Chronic Liver Failure): un patient est décédé, le second a été transplanté et le troisième a récupéré sous traitement par ribavirine. Un traitement par ribavirine a été mis en place chez 27,6 % des patients. La guérison après premier traitement était de 79,3%. Conclusion : Le virus de l'hépatite E, sur la période 2012-2018 a représenté une cause non négligeable d'hépatite dans notre région avec une transmission majoritairement zoonotique, ans et le sex-ratio était de 3/1. La voie principale de contamination retrouvée était une consommation de viande porcine insuffisamment cuite
, Virus de l'hépatite E, zoonose, France, immunodépression, transplantation, cirrhose, carcinome hépatocellulaire, ribavirine, étude rétrospective